Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
465 GBX | -0.85% | +9.67% | +27.40% |
Apr. 24 | EDX Medical to begin trading on Apex segment of AQSE next week | AN |
Apr. 23 | Marula reaches "significant milestone" for Tanzanian graphite projects | AN |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 158.2 | 109.1 | 127.7 | 173.3 | 103.5 | 122.9 | 122.9 | - |
Enterprise Value (EV) 1 | 146.6 | 98.14 | 115.4 | 159.2 | 89.3 | 84.61 | 106.6 | 101.4 |
P/E ratio | - | - | - | 42 x | 23.8 x | 19.2 x | 20.8 x | 20.7 x |
Yield | - | - | - | - | - | - | - | - |
Capitalization / Revenue | 39.7 x | 15.8 x | 11.1 x | 10.1 x | 5.19 x | 4.19 x | 4.73 x | 4.24 x |
EV / Revenue | 36.8 x | 14.2 x | 10.1 x | 9.27 x | 4.48 x | 3.57 x | 4.1 x | 3.5 x |
EV / EBITDA | -47.6 x | -491 x | 77 x | 37.2 x | 15.4 x | 13.5 x | 14.1 x | 11.7 x |
EV / FCF | - | - | 50.5 x | 56.6 x | 27.5 x | 22.9 x | 18.4 x | 19.9 x |
FCF Yield | - | - | 1.98% | 1.77% | 3.63% | 4.36% | 5.44% | 5.03% |
Price to Book | - | - | - | - | - | 3.54 x | 3.73 x | 3.27 x |
Nbr of stocks (in thousands) | 27,641 | 27,150 | 27,170 | 27,505 | 27,230 | 26,433 | 26,433 | - |
Reference price 2 | 5.725 | 4.020 | 4.700 | 6.300 | 3.800 | 4.650 | 4.650 | 4.650 |
Announcement Date | 3/20/19 | 4/16/20 | 3/31/21 | 3/29/22 | 3/30/23 | 3/21/24 | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 3.982 | 6.892 | 11.48 | 17.18 | 19.93 | 23.71 | 26 | 28.97 |
EBITDA 1 | -3.083 | -0.2 | 1.5 | 4.28 | 5.81 | 6.27 | 7.55 | 8.65 |
EBIT 1 | - | - | - | 3.248 | 4.551 | 4.898 | 6.926 | 8.006 |
Operating Margin | - | - | - | 18.9% | 22.83% | 20.66% | 26.63% | 27.64% |
Earnings before Tax (EBT) 1 | - | - | - | 3.222 | 4.526 | 5.195 | 6.28 | 7.327 |
Net income 1 | - | - | - | 4.311 | 4.684 | 5.203 | 6.3 | 6.35 |
Net margin | - | - | - | 25.09% | 23.5% | 21.94% | 24.23% | 21.92% |
EPS 2 | - | - | - | 0.1500 | 0.1600 | 0.1900 | 0.2240 | 0.2250 |
Free Cash Flow 1 | - | - | 2.287 | 2.812 | 3.245 | 3.692 | 5.8 | 5.1 |
FCF margin | - | - | 19.92% | 16.36% | 16.28% | 15.57% | 22.3% | 17.6% |
FCF Conversion (EBITDA) | - | - | 152.45% | 65.69% | 55.86% | 58.89% | 76.82% | 58.96% |
FCF Conversion (Net income) | - | - | - | 65.23% | 69.29% | 70.97% | 92.06% | 80.31% |
Dividend per Share 2 | - | - | - | - | - | - | - | - |
Announcement Date | 3/20/19 | 4/16/20 | 3/31/21 | 3/29/22 | 3/30/23 | 3/21/24 | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - | - | - |
Net Cash position 1 | 11.6 | 11 | 12.3 | 14 | 14.2 | 14.8 | 16.3 | 21.6 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
Free Cash Flow 1 | - | - | 2.29 | 2.81 | 3.25 | 3.69 | 5.8 | 5.1 |
ROE (net income / shareholders' equity) | - | - | - | 18.6% | 21.8% | 20.1% | 19.2% | 16.2% |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - | - |
Book Value Per Share 2 | - | - | - | - | - | 1.030 | 1.250 | 1.420 |
Cash Flow per Share | - | - | - | - | - | - | - | - |
Capex 1 | 0.42 | - | - | 0.32 | - | 0.41 | 2 | 1.9 |
Capex / Sales | 10.6% | - | - | 1.86% | - | 1.73% | 7.69% | 6.56% |
Announcement Date | 3/20/19 | 4/16/20 | 3/31/21 | 3/29/22 | 3/30/23 | 3/21/24 | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+27.40% | 153M | |
+0.16% | 75.94B | |
+12.06% | 21.7B | |
+27.19% | 12.54B | |
+39.83% | 8.36B | |
+44.53% | 5.21B | |
-2.16% | 2.96B | |
+30.25% | 2.55B | |
-5.45% | 1.69B | |
+15.14% | 1.29B |
- Stock Market
- Equities
- AQX Stock
- Financials Aquis Exchange PLC